23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › INSMED INC. › 2023-2024

INSMED INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and INSMED INC.’s Form 8-K, filed May 13, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 7Ballot items
  • 319Asset managers, any item
  • 2,800Fund votes
  • May 13, 2024Meeting date

Results at a glance

Meeting of May 13, 2024: 7 items on INSMED INC.’s Form 8-K, filed May 13, 2024: 3 approved · 4 passed (calculated).

Dissent

Notable dissent: 1 director (11.6% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore INSMED INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by INSMED INC.

These tallies are INSMED INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

INSMED INC. — official shareholder meeting results, meeting held May 13, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: David R. Brennan 120,537,761---- 8,278,23610,923,081 94%Passed (calculated)—
Elect Director: Leo Lee 125,634,442---- 3,181,55510,923,081 98%Passed (calculated)—
Elect Director: Carol A. Schafer 113,910,394---- 14,905,60310,923,081 88%Passed (calculated)—
Elect Director: Melvin Sharoky, M.D. 117,140,717---- 11,675,28010,923,081 91%Passed (calculated)—
2. Advisory Vote on the 2023 Compensation of Named Executive Officers 120,643,0458,076,14496,808 --10,923,081 94%Approved—
3. Ratification of the Appointment of an Independent Registered Public Accounting Firm 135,507,0264,170,27961,773 ---- 97%Approved—
4. Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan 122,169,8236,589,41456,760 --10,923,081 95%Approved—

Source: INSMED INC., Form 8-K, filed with the SEC on May 13, 2024 — read the filing on EDGAR.

How asset managers voted at the INSMED INC. 2023-2024 meeting

319 asset managers disclosed a vote on at least one INSMED INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: David R. Brennan

Calculated outcomeFund totals may overlapDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 120,537,761WITHHELD: 8,278,236
Details: description as filed, official tally, votes by 100 asset managers

Description as filed by funds: Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: David R. Brennan

INSMED INC.’s own tally for this item (“Elect Director: David R. Brennan”): 120,537,761 for, 8,278,236 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 96 asset managers voting on “Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., t” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard14,238,0020 00For
T. Rowe Price8,369,1150 02,263,126Mixed
Fidelity9,935,4910 00For
BlackRock3,405,1450 00For
State Street3,065,6080 0391For
Delaware/Macquarie2,267,1330 00For
Columbia Threadneedle1,625,5870 00For
FRANKLIN STRATEGIC SERIES1,598,7400 00For
First Trust1,465,6260 00For
JANUS INVESTMENT FUND1,399,0270 00For
BNY Mellon1,153,2170 00For
Charles Schwab1,152,8730 00For
AllianceBernstein1,138,1490 00For
Principal751,6390 0255,620Mixed
WILLIAM BLAIR FUNDS909,9710 00For
Waddell & Reed654,5150 00For
MUTUAL FUND SERIES TRUST635,1850 00For
American Century614,6190 00For
Loomis Sayles543,3060 00For
TIAA518,1660 00For
Legg Mason477,3000 00For
Manager Directed Portfolios447,8920 00For
FINANCIAL INVESTORS TRUST00 396,8870Abstain
Equitable395,0800 00For
Putnam392,9200 00For

Fund voting reports, all 96 managers: 62,026,316 for, 2,758,911 withheld, 412,886 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 4 asset managers voting on “Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., t” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP10,600,0000 00For
Altium Capital Management LP120,0000 00For
Erste Asset Management GmbH47,6000 00For
Keel Point, LLC700 00For

Institutional-manager reports, all 4 managers: 10,767,670 for.

Elect Director: Carol A. Schafer

Calculated outcomeFund totals may overlapDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%
FOR: 113,910,394WITHHELD: 14,905,603
Details: description as filed, official tally, votes by 99 asset managers

Description as filed by funds: Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Carol A. Schafer

INSMED INC.’s own tally for this item (“Elect Director: Carol A. Schafer”): 113,910,394 for, 14,905,603 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 95 asset managers voting on “Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., t” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard14,238,0020 00For
T. Rowe Price8,369,1150 02,263,126Mixed
Fidelity9,935,4910 00For
BlackRock3,405,1450 00For
State Street3,065,2160 0783For
Delaware/Macquarie2,267,1330 00For
Columbia Threadneedle1,625,5870 00For
FRANKLIN STRATEGIC SERIES1,598,7400 00For
First Trust1,465,6260 00For
JANUS INVESTMENT FUND1,399,0270 00For
BNY Mellon1,153,2170 00For
Charles Schwab00 01,152,873Withhold
AllianceBernstein00 01,138,149Withhold
Principal519,2420 0488,017Mixed
WILLIAM BLAIR FUNDS909,9710 00For
Waddell & Reed654,5150 00For
American Century614,6190 00For
Loomis Sayles00 543,3060Abstain
TIAA518,1660 00For
Legg Mason477,3000 00For
Manager Directed Portfolios447,8920 00For
FINANCIAL INVESTORS TRUST00 396,8870Abstain
Equitable243,7600 0151,320Mixed
Putnam392,9200 00For
John Hancock346,4100 11,2880For

Fund voting reports, all 95 managers: 57,875,529 for, 5,710,288 withheld, 977,111 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 4 asset managers voting on “Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., t” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP10,600,0000 00For
Altium Capital Management LP120,0000 00For
Erste Asset Management GmbH47,6000 00For
Keel Point, LLC700 00For

Institutional-manager reports, all 4 managers: 10,767,670 for.

Elect Director: Leo Lee

Calculated outcomeFund totals may overlapDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 125,634,442WITHHELD: 3,181,555
Details: description as filed, official tally, votes by 99 asset managers

Description as filed by funds: Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Leo Lee

INSMED INC.’s own tally for this item (“Elect Director: Leo Lee”): 125,634,442 for, 3,181,555 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 95 asset managers voting on “Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., t” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard14,238,0020 00For
T. Rowe Price10,632,2410 00For
Fidelity9,935,4910 00For
BlackRock3,405,1450 00For
State Street3,065,6080 0391For
Delaware/Macquarie2,267,1330 00For
Columbia Threadneedle1,625,5870 00For
FRANKLIN STRATEGIC SERIES1,598,7400 00For
First Trust1,465,6260 00For
JANUS INVESTMENT FUND1,399,0270 00For
BNY Mellon1,153,2170 00For
Charles Schwab1,152,8730 00For
AllianceBernstein1,138,1490 00For
Principal751,6390 0255,620Mixed
WILLIAM BLAIR FUNDS909,9710 00For
Waddell & Reed654,5150 00For
American Century614,6190 00For
Loomis Sayles543,3060 00For
TIAA518,1660 00For
Legg Mason477,3000 00For
Manager Directed Portfolios447,8920 00For
FINANCIAL INVESTORS TRUST00 396,8870Abstain
Equitable395,0800 00For
Putnam392,9200 00For
John Hancock357,6980 00For

Fund voting reports, all 95 managers: 63,772,083 for, 392,658 withheld, 398,187 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 4 asset managers voting on “Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., t” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP10,600,0000 00For
Altium Capital Management LP120,0000 00For
Erste Asset Management GmbH47,6000 00For
Keel Point, LLC700 00For

Institutional-manager reports, all 4 managers: 10,767,670 for.

Elect Director: Melvin Sharoky, M.D.

Calculated outcomeFund totals may overlapDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 117,140,717WITHHELD: 11,675,280
Details: description as filed, official tally, votes by 99 asset managers

Description as filed by funds: Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Melvin Sharoky, M.D.

INSMED INC.’s own tally for this item (“Elect Director: Melvin Sharoky, M.D.”): 117,140,717 for, 11,675,280 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 95 asset managers voting on “Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., t” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard14,238,0020 00For
T. Rowe Price8,369,1150 02,263,126Mixed
Fidelity9,935,4910 00For
BlackRock3,405,1450 00For
State Street3,064,7350 01,264For
Delaware/Macquarie2,267,1330 00For
Columbia Threadneedle1,625,5870 00For
FRANKLIN STRATEGIC SERIES1,598,7400 00For
First Trust1,465,6260 00For
JANUS INVESTMENT FUND1,399,0270 00For
BNY Mellon1,153,2170 00For
Charles Schwab1,152,8730 00For
AllianceBernstein00 01,138,149Withhold
Principal519,2420 0488,017Mixed
WILLIAM BLAIR FUNDS909,9710 00For
Waddell & Reed654,5150 00For
American Century614,6190 00For
Loomis Sayles543,3060 00For
TIAA518,1660 00For
Legg Mason477,3000 00For
Manager Directed Portfolios447,8920 00For
FINANCIAL INVESTORS TRUST00 396,8870Abstain
Equitable243,7600 0151,320Mixed
Putnam392,9200 00For
John Hancock346,4100 11,2880For

Fund voting reports, all 95 managers: 59,650,653 for, 4,495,658 withheld, 416,617 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 4 asset managers voting on “Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., t” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
RWC Asset Management LLP10,600,0000 00For
Altium Capital Management LP120,0000 00For
Erste Asset Management GmbH47,6000 00For
Keel Point, LLC700 00For

Institutional-manager reports, all 4 managers: 10,767,670 for.

Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan

Official resultFund totals may overlapCOMPENSATIONReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 122,169,823AGAINST: 6,589,414
Details: description as filed, official tally, votes by 101 asset managers

Description as filed by funds: Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan.

INSMED INC.’s own tally for this item (“4. Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan”): 122,169,823 for, 6,589,414 against — passed, per its Form 8-K filed May 13, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the following vote, shareholders approved Amendment No. 1 to the 2019 Incentive Plan:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of INSMED INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (2 managers, 80,869 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 96 asset managers voting on “Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan.” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard14,238,0020 00For
T. Rowe Price10,632,2410 00For
Fidelity9,678,430257,061 00For
BlackRock3,405,1450 00For
State Street3,065,517482 00For
Delaware/Macquarie2,267,1330 00For
Columbia Threadneedle1,625,5870 00For
FRANKLIN STRATEGIC SERIES1,598,7400 00For
First Trust1,465,6260 00For
JANUS INVESTMENT FUND1,399,0270 00For
BNY Mellon1,153,2170 00For
Charles Schwab1,152,8730 00For
AllianceBernstein1,138,1490 00For
Principal1,007,2590 00For
WILLIAM BLAIR FUNDS909,9710 00For
Waddell & Reed654,5150 00For
MUTUAL FUND SERIES TRUST635,1850 00For
American Century0614,619 00Against
Loomis Sayles543,3060 00For
TIAA518,1660 00For
Legg Mason477,3000 00For
Manager Directed Portfolios447,8920 00For
FINANCIAL INVESTORS TRUST396,8870 00For
Equitable395,0800 00For
Putnam0392,920 00Against

Fund voting reports, all 96 managers: 63,289,106 for, 1,867,887 against, 41,120 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 4 asset managers voting on “Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan.” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Palo Alto Investors LP5,484,9640 00For
First Light Asset Management, LLC275,1540 00For
Altium Capital Management LP120,0000 00For
Keel Point, LLC700 00For

Institutional-manager reports, all 4 managers: 5,880,188 for.

Advisory Vote on the 2023 Compensation of Named Executive Officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 12 wordings of this item as funds reported it.

94% Approved · of votes cast

FOR 94%
FOR: 120,643,045AGAINST: 8,076,144

Prior year: 95.6% for (May 11, 2023 meeting) ▼ 1.9 pts

Details: description as filed, official tally, votes by 317 asset managers

Description as filed by funds: An advisory vote on the 2023 compensation of our named executive officers.

INSMED INC.’s own tally for this item (“2. Advisory Vote on the 2023 Compensation of Named Executive Officers”): 120,643,045 for, 8,076,144 against — passed, per its Form 8-K filed May 13, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the following vote, shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers, as disclosed in the Proxy Statement:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 97 asset managers voting on “An advisory vote on the 2023 compensation of our named executive officers.” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard14,238,0020 00For
T. Rowe Price10,632,2410 00For
Fidelity9,935,4910 00For
BlackRock3,405,1450 00For
State Street3,065,9990 00For
Delaware/Macquarie2,267,1330 00For
Columbia Threadneedle1,625,5870 00For
FRANKLIN STRATEGIC SERIES1,598,7400 00For
First Trust1,465,6260 00For
JANUS INVESTMENT FUND1,399,0270 00For
BNY Mellon13,5311,139,686 00Against
Charles Schwab1,152,8730 00For
AllianceBernstein1,138,1490 00For
Principal1,007,2590 00For
WILLIAM BLAIR FUNDS909,9710 00For
Waddell & Reed654,5150 00For
MUTUAL FUND SERIES TRUST635,1850 00For
American Century0614,619 00Against
Loomis Sayles543,3060 00For
TIAA518,1660 00For
Legg Mason477,3000 00For
Manager Directed Portfolios447,8920 00For
FINANCIAL INVESTORS TRUST396,8870 00For
Equitable395,0800 00For
Putnam392,9200 00For

Fund voting reports, all 97 managers: 63,168,901 for, 1,993,748 against, 41,120 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 247 asset managers voting on “An advisory vote on the 2023 compensation of our named executive officers.” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price14,309,8940 00For
Fidelity6,988,921740,920 00Mixed
State Street5,754,4220 00For
Palo Alto Investors LP5,484,9640 00For
Deep Track Capital, LP4,783,6790 00For
BlackRock4,031,6050 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST3,482,3210 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC3,471,0700 00For
GEODE CAPITAL MANAGEMENT, LLC3,138,8680 00For
FRANKLIN ADVISERS INC3,037,1700 00For
Janus Henderson2,030,2680 00For
SUVRETTA CAPITAL MANAGEMENT, LLC1,965,4970 00For
AllianceBernstein1,920,6240 00For
RTW INVESTMENTS, LP1,795,9840 00For
Newton Investment Management North America, LLC01,414,080 00Against
PICTET ASSET MANAGEMENT SA1,363,9030 00For
Novo Holdings A/S1,339,3040 00For
Octagon Capital Advisors LP1,284,0000 00For
Charles Schwab1,185,9170 00For
GW&K Investment Management, LLC1,100,2749,997 00For
Clearbridge Investments, LLC930,0350 00For
BNP Paribas Asset Management Holding S.A.0898,733 00Against
Hood River Capital Management LLC877,9710 00For
Northern Trust858,73096 00For
EMERALD MUTUAL FUND ADVISERS TRUST748,0340 00For

Institutional-manager reports, all 247 managers: 87,113,203 for, 6,610,871 against, 25,000 abstained, 65 not voted, 10 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the Appointment of an Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 135,507,026AGAINST: 4,170,279

Prior year: 96.2% for (May 11, 2023 meeting) ▲ 0.8 pts

Details: description as filed, official tally, votes by 98 asset managers

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024.

INSMED INC.’s own tally for this item (“3. Ratification of the Appointment of an Independent Registered Public Accounting Firm”): 135,507,026 for, 4,170,279 against — passed, per its Form 8-K filed May 13, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 98 asset managers below reported 65,090,247 for, 186,816 against, 41,120 abstained.

FOR
FOR: 65,090,247AGAINST: 186,816ABSTAIN: 41,120
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for ” at INSMED INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard14,238,0020 00For
T. Rowe Price10,632,2410 00For
Fidelity9,935,4910 00For
BlackRock3,405,1450 00For
State Street3,065,517482 00For
Delaware/Macquarie2,267,1330 00For
Columbia Threadneedle1,625,5870 00For
FRANKLIN STRATEGIC SERIES1,598,7400 00For
First Trust1,465,6260 00For
JANUS INVESTMENT FUND1,399,0270 00For
BNY Mellon1,153,2170 00For
Charles Schwab1,152,8730 00For
AllianceBernstein1,138,1490 00For
Principal1,007,2590 00For
WILLIAM BLAIR FUNDS909,9710 00For
Waddell & Reed654,5150 00For
MUTUAL FUND SERIES TRUST635,1850 00For
American Century614,6190 00For
Loomis Sayles543,3060 00For
TIAA518,1660 00For
Legg Mason477,3000 00For
Manager Directed Portfolios447,8920 00For
FINANCIAL INVESTORS TRUST396,8870 00For
Equitable395,0800 00For
Putnam392,9200 00For

Showing the 25 largest of 98 asset managers. All 98 are in the interactive database (link above).

Largest INSMED INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 148,560,882 shares outstanding at the time of that meeting.

Fund voting reports: top INSMED INC. shareholders by shares voted on “An advisory vote on the 2023 compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 9.58%
2T. Rowe Price 7.16%
3Fidelity 6.69%
4BlackRock 2.29%
5State Street 2.06%
6Delaware/Macquarie 1.53%
7Columbia Threadneedle 1.09%
8FRANKLIN STRATEGIC SERIES 1.08%
9First Trust 0.99%
10JANUS INVESTMENT FUND 0.94%
Institutional-manager reports: top INSMED INC. shareholders by shares voted on “An advisory vote on the 2023 compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1T. Rowe Price 9.63%
2Fidelity 5.20%
3State Street 3.87%
4Palo Alto Investors LP 3.69%
5Deep Track Capital, LP 3.22%
6BlackRock 2.71%
7MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST 2.34%
8WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.34%
9GEODE CAPITAL MANAGEMENT, LLC 2.11%
10FRANKLIN ADVISERS INC 2.04%

Reported INSMED INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

INSMED INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
JPMorgan Chase23,047,676 15.51%Form 13F, quarter ended March 31, 2024
Vanguard Group19,935,820 13.42%Form 13F, quarter ended March 31, 2024
BlackRock12,364,904 8.32%Form 13F, quarter ended March 31, 2024
T. Rowe Price10,769,366 7.25%Form 13F, quarter ended March 31, 2024
FMR (Fidelity)9,180,963 6.18%Form 13F, quarter ended March 31, 2024
State Street5,905,127 3.97%Form 13F, quarter ended March 31, 2024
Franklin Templeton3,567,013 2.40%Form 13F, quarter ended March 31, 2024
Geode Capital3,163,751 2.13%Form 13F, quarter ended March 31, 2024
BNY Mellon2,051,311 1.38%Form 13F, quarter ended March 31, 2024
Capital International1,620,814 1.09%Form 13F, quarter ended March 31, 2024

Percentages above are of 148,560,882 shares outstanding, as reported by INSMED INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At INSMED INC.'s shareholder meeting held May 13, 2024, in the 2023-2024 proxy season, 319 asset managers reported votes on at least one of its 7 ballot items in their SEC Form N-PX filings, covering 2,800 separate fund positions. On the most widely held item on that ballot — An advisory vote on the 2023 compensation of our named executive officers. — INSMED INC.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: INSMED INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 13, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from INSMED INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

INSMED INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “INSMED (INSM) 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/insmed-incorporated/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.